EHRA Premium Access

Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation? - Results of the EORP AF Ablation Long-Term Registry

Congress Presentation

About the speaker

Professor Daniel Scherr

Medical University of Graz, Graz (Austria)
14 presentations
0 follower

7 more presentations in this session

Uninterrupted Direct Oral Anticoagulant therapy is an efficacious and safer alternative to Vitamin K Antagonists in patients undergoing catheter ablation for atrial fibrillation. A meta-analysis

Speaker: Mr M. Ottoffy (Pecs, HU)


Ablation Strategies for different types of atrial fibrillation in Europe - Results of the EORP Atrial Fibrillation Ablation Long-Term Registry

Speaker: Doctor B. Schmidt (Frankfurt, DE)


No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry

Speaker: Doctor C. Jilek (Munich, DE)


Markedly reduced fluoroscopy time in catheter ablation: data from the Swedish national catheter ablation registry

Speaker: Doctor M. Ringborn (Karlskrona, SE)


Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicenter LAGO-AF Study

Speaker: Doctor F. Bisbal (Barcelona, ES)


Access the full session

Atrial fibrillation ablation - Multicenter studies and registries

Speakers: Professor D. Scherr, Mr M. Ottoffy, Doctor B. Schmidt, Doctor C. Jilek, Doctor M. Ringborn...

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb